The number of medical device IPOs doubled last year, rising from 12 to 24, as companies found public investors in the U.S. and China willing to buy their stock. By the end of the year, six of the class of 2021 had market caps in excess of $1 billion, although only two of them, Paragon 28 and Sight Sciences, were listed in the U.S.
